Coherus Biosciences reported $140.75M in Current Liabilities for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Aerie Pharmaceuticals AERI:US $ 119.66M 4.37M
Akebia Therapeutics AKBA:US $ 233.68M 20.23M
ALKERMES ALKS:US $ 438.52M 23.84M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amarin AMRN:US $ 361.57M 61M
Amgen AMGN:US $ 12618M 268M
Baxter International BAX:US $ 3916M 26M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Coherus Biosciences CHRS:US $ 140.75M 12.99M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Endo International Ordinary Shares ENDP:US $ 1181.67M 194.47M
Fujifilm 4901:JP Y 994130M 14555M
Gilead Sciences GILD:US $ 9220M 662M
Horizon Pharma HZNP:US $ 791.06M 34.12M
Ironwood Pharmaceuticals IRWD:US $ 23.3M 124.1M
JAZZ PHA JAZZ:US $ 705.44M 31.97M
LG Chem 051910:KS KW 16965848M 1903752M
Myriad Genetics MYGN:US $ 119.7M 46.3M
Pacira Pharmaceuticals PCRX:US $ 133.18M 171.89M
Perrigo Ordinary Shares PRGO:US $ 1014.6M 33.3M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Revance Therapeutics RVNC:US $ 77.23M 6.16M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Teva Pharmaceutical TEVA:IT 11B 617M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
Xencor XNCR:US $ 75.04M 14.1M
Zoetis ZTS:US $ 3051M 17M